nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—GABRA4—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0175	0.0254	CbGpPWpGaD
Eszopiclone—GABRB2—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.016	0.0232	CbGpPWpGaD
Eszopiclone—GABRA5—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0156	0.0225	CbGpPWpGaD
Eszopiclone—GABRA3—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0153	0.0221	CbGpPWpGaD
Eszopiclone—GABRA2—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.015	0.0218	CbGpPWpGaD
Eszopiclone—GABRG2—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0147	0.0212	CbGpPWpGaD
Eszopiclone—GABRA5—forebrain—attention deficit hyperactivity disorder	0.0132	0.0426	CbGeAlD
Eszopiclone—GABRA1—Ligand-gated ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0128	0.0185	CbGpPWpGaD
Eszopiclone—GABRA4—forebrain—attention deficit hyperactivity disorder	0.0119	0.0387	CbGeAlD
Eszopiclone—GABRG3—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0101	0.0146	CbGpPWpGaD
Eszopiclone—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00999	0.0323	CbGeAlD
Eszopiclone—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00999	0.0323	CbGeAlD
Eszopiclone—GABRA4—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0093	0.0135	CbGpPWpGaD
Eszopiclone—GABRG3—nervous system—attention deficit hyperactivity disorder	0.0093	0.0301	CbGeAlD
Eszopiclone—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00913	0.0295	CbGeAlD
Eszopiclone—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.00895	0.029	CbGeAlD
Eszopiclone—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00882	0.0286	CbGeAlD
Eszopiclone—GABRB2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00851	0.0123	CbGpPWpGaD
Eszopiclone—TSPO—forebrain—attention deficit hyperactivity disorder	0.00845	0.0274	CbGeAlD
Eszopiclone—GABRA5—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00826	0.012	CbGpPWpGaD
Eszopiclone—GABRA3—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00811	0.0117	CbGpPWpGaD
Eszopiclone—GABRA2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00797	0.0115	CbGpPWpGaD
Eszopiclone—GABRG2—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.00778	0.0113	CbGpPWpGaD
Eszopiclone—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00715	0.0231	CbGeAlD
Eszopiclone—TSPO—cardiovascular system—attention deficit hyperactivity disorder	0.00715	0.0231	CbGeAlD
Eszopiclone—GABRG3—brain—attention deficit hyperactivity disorder	0.00711	0.023	CbGeAlD
Eszopiclone—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.00688	0.0223	CbGeAlD
Eszopiclone—GABRA1—GABA receptor activation—GABRQ—attention deficit hyperactivity disorder	0.0068	0.00984	CbGpPWpGaD
Eszopiclone—GABRA3—nervous system—attention deficit hyperactivity disorder	0.00665	0.0215	CbGeAlD
Eszopiclone—GABRG2—midbrain—attention deficit hyperactivity disorder	0.0066	0.0214	CbGeAlD
Eszopiclone—GABRB2—midbrain—attention deficit hyperactivity disorder	0.0066	0.0214	CbGeAlD
Eszopiclone—GABRA4—nervous system—attention deficit hyperactivity disorder	0.00648	0.021	CbGeAlD
Eszopiclone—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.00641	0.0207	CbGeAlD
Eszopiclone—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.00624	0.0202	CbGeAlD
Eszopiclone—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.0061	0.0197	CbGeAlD
Eszopiclone—GABRG3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00589	0.00853	CbGpPWpGaD
Eszopiclone—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00583	0.0189	CbGeAlD
Eszopiclone—TSPO—midbrain—attention deficit hyperactivity disorder	0.00558	0.0181	CbGeAlD
Eszopiclone—GABRA5—brain—attention deficit hyperactivity disorder	0.00546	0.0177	CbGeAlD
Eszopiclone—GABRG2—nervous system—attention deficit hyperactivity disorder	0.00542	0.0176	CbGeAlD
Eszopiclone—GABRB2—nervous system—attention deficit hyperactivity disorder	0.00542	0.0176	CbGeAlD
Eszopiclone—GABRA4—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00542	0.00785	CbGpPWpGaD
Eszopiclone—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.00522	0.0169	CbGeAlD
Eszopiclone—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.00522	0.0169	CbGeAlD
Eszopiclone—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.0051	0.0165	CbGeAlD
Eszopiclone—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.0051	0.0165	CbGeAlD
Eszopiclone—GABRA3—brain—attention deficit hyperactivity disorder	0.00509	0.0165	CbGeAlD
Eszopiclone—GABRB2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00496	0.00718	CbGpPWpGaD
Eszopiclone—GABRA4—brain—attention deficit hyperactivity disorder	0.00496	0.016	CbGeAlD
Eszopiclone—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00496	0.016	CbGeAlD
Eszopiclone—GABRA5—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00482	0.00697	CbGpPWpGaD
Eszopiclone—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00479	0.0155	CbGeAlD
Eszopiclone—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.00477	0.0154	CbGeAlD
Eszopiclone—GABRA3—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00473	0.00685	CbGpPWpGaD
Eszopiclone—PTGS1—forebrain—attention deficit hyperactivity disorder	0.0047	0.0152	CbGeAlD
Eszopiclone—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.00466	0.0151	CbGeAlD
Eszopiclone—GABRA2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00465	0.00673	CbGpPWpGaD
Eszopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00465	0.00672	CbGpPWpGaD
Eszopiclone—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00461	0.0149	CbGeAlD
Eszopiclone—TSPO—nervous system—attention deficit hyperactivity disorder	0.00459	0.0148	CbGeAlD
Eszopiclone—GABRG2—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00454	0.00657	CbGpPWpGaD
Eszopiclone—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.00451	0.0146	CbGeAlD
Eszopiclone—TSPO—central nervous system—attention deficit hyperactivity disorder	0.00442	0.0143	CbGeAlD
Eszopiclone—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00436	0.0141	CbGeAlD
Eszopiclone—TSPO—cerebellum—attention deficit hyperactivity disorder	0.00432	0.014	CbGeAlD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00428	0.00619	CbGpPWpGaD
Eszopiclone—GABRB2—brain—attention deficit hyperactivity disorder	0.00415	0.0134	CbGeAlD
Eszopiclone—GABRG2—brain—attention deficit hyperactivity disorder	0.00415	0.0134	CbGeAlD
Eszopiclone—GABRG3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00413	0.00598	CbGpPWpGaD
Eszopiclone—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.00398	0.0129	CbGeAlD
Eszopiclone—GABRA1—Orphan transporters—GABRQ—attention deficit hyperactivity disorder	0.00397	0.00574	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00391	0.00566	CbGpPWpGaD
Eszopiclone—GABRA4—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.0038	0.00551	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.0038	0.0055	CbGpPWpGaD
Eszopiclone—GABRA2—brain—attention deficit hyperactivity disorder	0.00379	0.0123	CbGeAlD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00373	0.0054	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00367	0.00531	CbGpPWpGaD
Eszopiclone—GABRA1—brain—attention deficit hyperactivity disorder	0.00366	0.0118	CbGeAlD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00358	0.00518	CbGpPWpGaD
Eszopiclone—TSPO—brain—attention deficit hyperactivity disorder	0.00351	0.0113	CbGeAlD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00349	0.00505	CbGpPWpGaD
Eszopiclone—GABRB2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00348	0.00504	CbGpPWpGaD
Eszopiclone—GABRA5—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00338	0.00489	CbGpPWpGaD
Eszopiclone—GABRA3—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00332	0.0048	CbGpPWpGaD
Eszopiclone—GABRA2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00326	0.00472	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00321	0.00465	CbGpPWpGaD
Eszopiclone—GABRG2—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00318	0.00461	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00313	0.00452	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00294	0.00425	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00286	0.00413	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.0028	0.00406	CbGpPWpGaD
Eszopiclone—GABRA1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00278	0.00403	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00276	0.00399	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00269	0.00389	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00268	0.00387	CbGpPWpGaD
Eszopiclone—PTGS1—nervous system—attention deficit hyperactivity disorder	0.00255	0.00826	CbGeAlD
Eszopiclone—GABRA4—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00246	0.00356	CbGpPWpGaD
Eszopiclone—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00246	0.00795	CbGeAlD
Eszopiclone—CYP2C8—brain—attention deficit hyperactivity disorder	0.00241	0.00779	CbGeAlD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00235	0.0034	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00225	0.00326	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00219	0.00317	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00215	0.00311	CbGpPWpGaD
Eszopiclone—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00213	0.0069	CbGeAlD
Eszopiclone—GABRA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00211	0.00306	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00206	0.00298	CbGpPWpGaD
Eszopiclone—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00205	0.00664	CbGeAlD
Eszopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00205	0.00296	CbGpPWpGaD
Eszopiclone—PTGS1—brain—attention deficit hyperactivity disorder	0.00195	0.00632	CbGeAlD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00188	0.00272	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0018	0.00261	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00179	0.00259	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00172	0.00249	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00167	0.00242	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00165	0.00238	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00164	0.00238	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00161	0.00234	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00157	0.00228	CbGpPWpGaD
Eszopiclone—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00155	0.00224	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00154	0.00222	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00151	0.00218	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00151	0.00218	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00147	0.00212	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00146	0.00212	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00144	0.00208	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00144	0.00208	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00143	0.00207	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00142	0.00205	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00141	0.00204	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00139	0.00201	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00138	0.00199	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00138	0.00199	CbGpPWpGaD
Eszopiclone—PTGS1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00137	0.00198	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00137	0.00198	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00132	0.00192	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00132	0.0019	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00129	0.00187	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00127	0.00184	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00127	0.00184	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00126	0.00183	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00126	0.00182	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00126	0.00182	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00123	0.00179	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00123	0.00178	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00121	0.00176	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00121	0.00175	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00121	0.00175	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.0012	0.00174	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.0012	0.00174	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00119	0.00172	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00118	0.00171	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00118	0.0017	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00118	0.0017	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00117	0.0017	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00117	0.0017	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00117	0.0017	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00117	0.00169	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00116	0.00168	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00116	0.00167	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00115	0.00167	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00115	0.00166	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00114	0.00164	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00113	0.00163	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00112	0.00162	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00111	0.0016	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.0011	0.00159	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.0011	0.00159	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.0011	0.00158	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00108	0.00157	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00108	0.00157	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00108	0.00156	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00108	0.00156	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00107	0.00155	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00105	0.00153	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00104	0.00151	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00103	0.0015	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00102	0.00148	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00101	0.00147	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00101	0.00146	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00101	0.00145	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000997	0.00144	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000992	0.00143	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00099	0.00143	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000981	0.00142	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000976	0.00141	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000968	0.0014	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000963	0.00139	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000962	0.00139	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000946	0.00137	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00093	0.00135	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000922	0.00133	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000922	0.00133	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000912	0.00132	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000907	0.00131	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000905	0.00131	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000898	0.0013	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000896	0.0013	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000886	0.00128	CbGpPWpGaD
Eszopiclone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000885	0.00128	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000883	0.00128	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00088	0.00127	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000879	0.00127	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00087	0.00126	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000864	0.00125	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000864	0.00125	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000857	0.00124	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000855	0.00124	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000852	0.00123	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000849	0.00123	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000843	0.00122	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000834	0.00121	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00083	0.0012	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000828	0.0012	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000824	0.00119	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000822	0.00119	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000798	0.00116	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000793	0.00115	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000784	0.00113	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00077	0.00111	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000764	0.00111	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000758	0.0011	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000751	0.00109	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000737	0.00107	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000733	0.00106	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000729	0.00105	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000728	0.00105	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000724	0.00105	CbGpPWpGaD
Eszopiclone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00072	0.00104	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00072	0.00104	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000699	0.00101	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000694	0.001	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000679	0.000982	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000674	0.000975	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000666	0.000964	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000662	0.000958	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000657	0.000951	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000655	0.000948	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00065	0.000941	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000639	0.000925	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000634	0.000918	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000559	0.000808	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000555	0.000803	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000525	0.000759	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000483	0.000699	CbGpPWpGaD
Eszopiclone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000475	0.000687	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000473	0.000685	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00047	0.00068	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000467	0.000676	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000442	0.000639	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000429	0.000621	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000421	0.00061	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000414	0.000599	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000404	0.000585	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000385	0.000558	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000383	0.000554	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000381	0.000552	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00038	0.00055	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000353	0.000511	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0003	0.000434	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000254	0.000368	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000252	0.000365	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000251	0.000363	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000207	0.000299	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000207	0.000299	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000204	0.000295	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000194	0.00028	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000189	0.000274	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000165	0.000239	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000158	0.000228	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000157	0.000228	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000134	0.000193	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000134	0.000193	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000131	0.00019	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000125	0.000181	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000124	0.00018	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000122	0.000177	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000121	0.000175	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000109	0.000157	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000109	0.000157	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000107	0.000155	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000107	0.000155	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000104	0.00015	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000102	0.000147	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.95e-05	0.000144	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.7e-05	0.000126	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.28e-05	0.00012	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	8.1e-05	0.000117	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	8.04e-05	0.000116	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.8e-05	0.000113	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.17e-05	0.000104	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.17e-05	0.000104	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.06e-05	0.000102	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	6.59e-05	9.54e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.56e-05	9.49e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	6.54e-05	9.47e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.35e-05	9.18e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.73e-05	8.3e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.46e-05	7.9e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	5.38e-05	7.78e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.35e-05	6.29e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.32e-05	6.25e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	3.47e-05	5.03e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.83e-05	4.09e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.86e-05	2.7e-05	CbGpPWpGaD
